Katrin Nitz
@KatrinNitz
Followers
90
Following
128
Media
2
Statuses
24
research fellow @MayoClinic - former PostDoc @ipekresearch enthusiastic about atherosclerosis and immune cells
Rochester, MN, USA
Joined September 2022
Out now: in the current issue of @CircRes – full access to our paper. Many thanks to all co-authors and special thanks to @AtzlerLab @mwl4a @LutgensEsther @ipekresearch
https://t.co/IMbCm6aTb5
ahajournals.org
Background: Amino acid metabolism is crucial for inflammatory processes during atherogenesis. The endogenous amino acid homoarginine is a robust biomarker for cardiovascular outcome and mortality...
0
2
12
Delighted to share this wonderful photo of past and present Chairs of the Gordon Research Conference on Atherosclerosis. A big thank you to Esther and Nick for curating such an inspiring scientific program and for your perfect organization of this outstanding 2025 meeting.
1
3
31
A problem with immune checkpoint inhibitors for cancer (11 drugs are approved) is that they can potentiate atherosclerosis, and we're learning how this happens @NatureCVR
https://t.co/ta6b9Gq5EQ
https://t.co/LF9UyI8zfw
@Lab__Williams @LutgensEsther @GiannarelliL
9
105
353
#VRIC24 is just one week away! Don't miss the opportunity to explore vascular research with leading experts including Drs. Katrin Nitz (@KatrinNitz), Filip Swirski, Kathryn Moore, Dianna Milewicz, and others. https://t.co/tX5oTeWnO6
1
1
2
Excited to share our latest review in @JACCJournals Basic to Translational Science: Costimulatory and Coinhibitory Immune Checkpoints in Atherosclerosis: Therapeutic Targets in Atherosclerosis? https://t.co/pGNeXrRz3n with @LutgensEsther. Many thanks to @mayocvonc and @LermanAmir
jacc.org
0
0
5
Had the fantastic opportunity to learn from middle school students as a judge at the Rochester Regional STEM Fair 2024🧐😀. I was thrilled to see the future generation’s interest and enthusiasm for STEM👏. Continue to MAKE BIG WAVES👩🔬🔬🔎👨🔬 .
0
0
5
Fantastic #art experience @rochartcenter. 👇Gallery tour with the artist @annelabovitz through her current exhibition "The Nexus of Well-Being and Art". Impressive, contemporary and creative work with color and light on a variety of backgrounds.
0
2
8
🔴 Non-canonical roles of non-coding RNAs 🧬 in the development and progression of atherosclerosis 🫀 - find out more in our newest #Openaccess review 📕! @ATHjournal @ncRNAworld @ipekresearch @YoungDZHK 👇👇 https://t.co/YakQa6ClDy
1
9
24
Finally online our latest work on the role of the epigenetic enzyme DOT1L in the regulation of inflammatory response in atherosclerosis!🧬🥳 @leonardo_elia @Manuela @gcondorelli @escardio @ehj_ed @ESC_Journals @HumanitasMilano @ipekresearch @YoungDZHK
https://t.co/xTA7OX48nM
academic.oup.com
AbstractAims. Histone H3 dimethylation at lysine 79 is a key epigenetic mark uniquely induced by methyltransferase disruptor of telomeric silencing 1-like
1
6
20
Nice way to start the weekend with our latest paper on how lipid-binding receptor GPR55 regulates B cells 👉just published @NatureCVR ! Great team effort led by @rakiphd and collaborators @5antus @LarsMaeg and many more @ipekresearch @CRC1123_Athero
nature.com
Nature Cardiovascular Research - Using various mouse models, human plaque data and isolated B cells combined with state-of-the-art imaging and transcriptomic analysis, the authors show that the...
9
19
73
Nitz & colleagues found #homoarginine reduces #atherosclerosis by inhibiting Myh9 in CD4 #Tcells, which modulates actin cytoskeleton, migration, & proliferation. https://t.co/YIAyxWaUAE
@AtzlerLab @Dori_Muc @5antus @Huveneers_Lab @mwl4a @EstherLutgens @ipekresearch
0
6
26
I am very proud to share our latest publication in which we show the mechanistic role of homoarginine in atherosclerosis to modulate CD4 T cell function via Myh9
🆕by Nitz et al #homoarginine 📉 #atherosclerosis by🛑 Myh9 in CD4 T cells @AtzlerLab @mwl4a @EstherLutgens
2
2
14